End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
109.1 BDT | -0.27% | -0.18% | -25.38% |
Sales 2024 * | 44.51B 381M | Sales 2025 * | 50.42B 431M | Capitalization | 48.67B 416M |
---|---|---|---|---|---|
Net income 2024 * | 5.25B 44.9M | Net income 2025 * | 6.24B 53.39M | EV / Sales 2024 * | 1.23 x |
Net Debt 2024 * | 5.96B 50.93M | Net Debt 2025 * | 878M 7.51M | EV / Sales 2025 * | 0.98 x |
P/E ratio 2024 * |
8.87
x | P/E ratio 2025 * |
7.23
x | Employees | 5,700 |
Yield 2024 * |
3.81% | Yield 2025 * |
4.82% | Free-Float | 76.68% |
1 day | -0.27% | ||
1 week | -0.18% | ||
1 month | -8.32% | ||
3 months | -17.97% | ||
6 months | -25.38% | ||
Current year | -25.38% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-30 | 109.1 | -0.27% | 109,993 |
24-05-29 | 109.4 | -2.93% | 62,404 |
24-05-28 | 112.7 | +1.26% | 145,316 |
24-05-27 | 111.3 | +4.12% | 166,025 |
24-05-26 | 106.9 | -2.20% | 106,802 |
End-of-day quote Dhaka S.E., May 29, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.38% | 415M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- BXPHARMA Stock